Reply to Anthony et al., "protecting Pyrazinamide, a priority for improving outcomes in multidrug-resistant tuberculosis treatment

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Article number	e00427-17
Journal	Antimicrobial agents and chemotherapy
Volume	61
Issue number	6
DOIs	https://doi.org/10.1128/AAC.00427-17
State	Published - Jun 2017

ASJC Scopus subject areas

@article{e4fd969ba5c24ac9a128bbe10cdb8351,

title = "Reply to Anthony et al., {"}protecting Pyrazinamide, a priority for improving outcomes in multidrug-resistant tuberculosis treatment",

author = "Fofana, {M. O.} and Dowdy, {D. W.}",

year = "2017",

month = jun,

doi = "10.1128/AAC.00427-17",

language = "English (US)",

volume = "61",

journal = "Antimicrobial Agents and Chemotherapy",

issn = "0066-4804",

publisher = "American Society for Microbiology",

number = "6",

}

TY - JOUR

T1 - Reply to Anthony et al., "protecting Pyrazinamide, a priority for improving outcomes in multidrug-resistant tuberculosis treatment

AU - Fofana, M. O.

AU - Dowdy, D. W.

PY - 2017/6

Y1 - 2017/6

UR - http://www.scopus.com/inward/record.url?scp=85019735395&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019735395&partnerID=8YFLogxK

U2 - 10.1128/AAC.00427-17

DO - 10.1128/AAC.00427-17

M3 - Letter

C2 - 28539499

AN - SCOPUS:85019735395

VL - 61

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

SN - 0066-4804

IS - 6

M1 - e00427-17

ER -